MetLife Investment Management, LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in LENZ

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$89,551

-$67,041 QoQ

Shares Held

9,787

0.0% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$89,551	9,787	0.0%	Shares	Defined	2026-05-14
2025-12-31	$156,592	9,787	0.0%	Shares	Defined	2026-02-12
2025-09-30	$455,878	9,787	-10.5%	Shares	Defined	2025-11-13
2025-06-30	$320,651	10,940	+42.8%	Shares	Defined	2025-08-13
2025-03-31	$196,912	7,659	-0.2%	Shares	Defined	2025-05-14
2024-12-31	$221,490	7,672	0.0%	Shares	Defined	2025-02-13
2024-09-30	$182,133	7,672	—	Shares	Defined	2024-11-13
2022-03-31 GRPH	—	20,146	+193.6%	Shares	Defined	2024-05-10
2021-09-30 GRPH	—	6,861	—	Shares	Defined	2024-05-17
No filing history on record for this holder in this stock.